The Value of Carlsson-Dent Questionnaire in Diagnosis of Gastroesophageal Reflux Disease in Area With Low Prevalence of Gastroesophageal Reflux Disease by Netinatsunton, Nisa et al.
JNM Journal of Neurogastroenterology and Motility 
Original Article
164
J Neurogastroenterol Motil,  Vol. 17  No. 2 April,  2011 
DOI: 10.5056/jnm.2011.17.2.164
ⓒ 2011 The Korean Society of Neurogastroenterology and Motility
J Neurogastroenterol Motil,  Vol. 17  No. 2 April,  2011
www.jnmjournal.org
The Value of Carlsson-Dent Questionnaire in 
Diagnosis of Gastroesophageal Reflux 
Disease in Area With Low Prevalence of 
Gastroesophageal Reflux Disease
Nisa Netinatsunton, Siriboon Attasaranya, Bancha Ovartlarnporn,* Sulee Sangnil, Sopa Boonviriya and Teerha Piratvisuth
NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Hatyai, 
Songkhla, Thailand
ㅋ
Background/Aims
Symptom-based diagnosis for gastroesophageal reflux disease (GERD) has been accepted in the population with high 
prevalence. Carlsson-Dent questionnaire (CDQ) is a standardized symptom-based diagnosis tool for GERD. The value of this tool 
in the population with low prevalence is unknown. The aim of this study was to determine CDQ performance for diagnosis 
of GERD in Thai population with low prevalence versus endoscopy or 24 hour pH monitoring. 
Methods
Patients with dyspepsia by Rome II criteria were recruited. All patients completed a Thai version of CDQ and underwent endo-
scopic examination. Those without esophagitis or peptic ulcer and positive CDQ score took pH monitoring.
Results
One hundred patients (68 female) with mean age ± SD of 45.6 ± 12.4 years were recruited. Six with Los Angeles grade A 
esophagitis had negative CDQ score. In 44 with positive CDQ score, 3 had Los Angeles grade B esophagitis and 41 had pH 
monitoring done with 8 having positive test. The GERD diagnosis by CDQ was confirmed in 11 of 44 patients (25%). CDQ 
detected 11 out of 17 GERD detected by endoscopy and  pH monitoring and the sensitivity of CDQ was 64%. 
Conclusions
CDQ diagnosed more GERD in Thai population with low prevalence compared with endoscopy and pH monitoring. This may 
be due to some patients with functional heartburn were picked up by CDQ and some patients with GERD were not detected 
by endoscopy and pH monitoring.
(J Neurogastroenterol Motil 2011;17:164-168)
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Introduction
Gastroesophageal reflux disease (GERD) is a common prob-
lem in general practice. The reported prevalence of GERD using 
different definitions varied from 10%-30% in the Western 
population.
1-3 The prevalence of GERD in Eastern Asia ranged 
from 2.5%-6.7% and 1 cross-sectional study from Singapore 
showed the prevalence of 10.5%.
4-6 No published data regarding 
the prevalence of GERD in Thailand are available. The study of 
Thai motility club using questionnaire reported 7.4% prevalence 
of GERD in community (unpublished data). The prevalence of 
esophagitis as detected by endoscopy from data collected by the 
stomach research group of Thailand during the process of devel-
oping dyspepsia guideline 10 years ago ranged from 4%-6% 
(unpublished data). We recently analyzed our prospectively stor-
ed computerized endoscopic database in 1,320 patients with dys-
pepsia between the year 2007-2008 and the prevalence of esoph-
agitis was 4% (unpublished data). Based on these data, the preva-
lence of GERD in Thailand seems to be the same as other East 
Asian countries. 
Heartburn and/or acid regurgitation are regarded as typical 
symptoms for GERD. Symptoms based-diagnosis is widely uti-
lized in the western countries with acceptable sensitivity and 
specificity.
7 Some structural questionnaires were developed to 
standardize the symptom- based diagnosis of GERD.
8-15 The 
studies evaluating the validity of these types of questionnaire have 
conflicting results with reported sensitivity of 60%-92%.
9-18 
Carlsson and colleagues developed a self-administered ques-
tionnaire that focused on the nature of the sensations experienced 
by the patient as well as provoking, exacerbating and relieving 
factors. The questionnaire had a sensitivity of 92% and specificity 
of 19% in diagnosis of GERD compared with endoscopic esoph-
agitis and 24 hour pH monitoring as standard.
13 The prevalence 
of GERD in the target population could influence the perform-
ance of symptom-based diagnosis of GERD.
5,7 The clinical value 
of this tool in the population with low prevalence of GERD is 
unknown. Thus, the aim of this study is to assess the usefulness of 
the Carlsson-Dent questionnaire (CDQ) in diagnosis of GERD 
in the population with low prevalence of GERD.
Materials and Methods
Patients
One hundred patients with dyspeptic symptoms by Rome II 
criteria with or without gastroesophageal reflux symptoms and 
age more than 18 years scheduled for endoscopy were pro-
spectively enrolled from May 2007 to January 2008. Patients 
were excluded if they had alarm symptoms, a history of docu-
mented ulcer disease, gastric surgery, gastric cancer, or severe 
concomitant medical conditions. An informed consent for each 
patient was obtained before the entry to the study.
Study Site
This study was conducted at the NKC Institute of Gastroen-
terology and Hepatology, Faculty of Medicine, Prince of Songkla 
University which is a tertiary referring center for gastroenterology 
in the South of Thailand. 
Study Protocol 
All patients completed the Thai version of CDQ that had 
been validated by back translation. CDQ score of equal to or 
greater than 4 is a positive score for GERD. The baseline charac-
teristics (age, gender, body weight, height, smoking history and 
drinking history), predominant symptoms and duration of symp-
toms before endoscopy were obtained.
Endoscopic examination was done in standard manner after 
patient had completed CDQ form. The endoscopists were not 
aware of patients’ CDQ score. The endoscopic diagnosis of 
esophagitis and grading were based on Los Angeles (LA) classi-
fication.
19 Barrett’s esophagus was defined as the presence of spe-
cialized columnar epithelium equal or more than three centi-
meters above the gastric fold with confirmed histological study.
20 
The significant findings were defined as gastric ulcer, gastric 
cancer, duodenal ulcer, severe erosive gastritis and severe erosive 
duodenitis.
Patients with erosive esophagitis, peptic ulcer, severe erosive 
gastritis, severe erosive duodenitis or score of CDQ less than 4 
did not proceed to have 24 hour pH monitoring done. Those 
with negative or insignificant findings from endoscopy and score 
of CDQ equal or greater than four were scheduled for 24 hour 
pH monitoring study (Figure).
The ambulatory 24 hour esophageal pH monitoring was 
done with a pH probe placed 6 centimeters above the proximal Nisa Netinatsunton, et al
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Figure. The flow diagram of the study. EGD, Esophago-gastroduodenal
endoscopy; LA, Los Angeles; CDQ, Carlsson-Dent questionnaire; 
GERD, gastroesophageal reflux disease.
Table 1. The Predominant Symptoms, Duration of Symptoms and 
Endoscopic Findings in 100 Patients
Number of 
patients
Predominant symptom 
Heartburn 37
Regurgitation 4
Upper abdominal pain 25
Nausea/vomiting 9
Other symptoms
a 25
Total 100
Duration of symptoms prior to endoscopy
＜ 1 mo 8
＞ 1 mo to 1 yr 50
＞ 1 yr  42
Total 100
Endoscopic finding 
Reflux esophagitis
Grade A 6
Grade B 3
Grade C 0
Grade D 0
Duodenal ulcer 1
Gastric ulcer 1
Non-erosive gastritis 12
Non-erosive duodenitis 4
Hiatal hernia 4
Gastric polyp 1
Normal findings 68
Total 100
aFullness, early satiety and discomfort.
margin of Z-line as measured during endoscopy while with-
drawing the gastroscope using Digitrapper
Ⓡ pH400 (Medtronic, 
Skovlunde, Denmark). Proton Pump inhibitor (PPI) was stop-
ped for at least 1 week before the study. Subjects were provided a 
diary to record meal times, position changes and the time and 
type of symptoms encountered during the recording period. They 
were specifically instructed to avoid acidic fluid such as citrus 
fruit juice or any condiment containing vinegar, to pursue their 
daily activities and to have their usual diet. Data of 24 hour pH 
study were analyzed by a computer software (Medtronic). A pos-
itive 24 hour pH monitoring study was defined by the percentage 
of total time of pH below 4 being more than 5%.
21 Patients with a 
positive test were diagnosed as having GERD.
Sample Size
Since there is no data regarding the performance of CDQ in 
low GERD prevalence population, 100 patients were arbitrarily 
selected to explore our concept. 
The study protocol has been approved by the ethic committee 
of the faculty of medicine, Prince of Songkla University.
Statistical Methods
Data were analyzed by descriptive statistics and were ex-
pressed as mean with standard deviation and as frequency with 
percentage where appropriate.
Results
There were 100 patients recruited from May 2007 to January 
2008 including 68 female and 32 male and the mean age ± SD 
was 45.6 ± 12.4 years with a range of 25-78 years. The predom-
inant symptoms were heartburn in 37 (37%), upper abdominal 
pain in 25 (25%), other symptoms (fullness, early satiety and dis-
comfort) in 25 (25%) nausea/vomiting in 9 (9%) and acid regur-
gitation in 4 (4%). The duration of symptoms was longer than 1 
month in 92% and 42% had symptoms for more than 1 year. The 
endoscopic examinations were normal in 68 (68%). Eleven pa-
tients had significant lesions, 9 with erosive esophagitis (6 of LA 
grade A and 3 of LA grade B), 1 with gastric ulcer and 1 with du-
odenal ulcer. Twenty-one patients had insignificant lesions in-
cluding 12 with gastritis, 4 with duodenitis, 4 with hiatal hernia 
and 1 with gastric polyp. None of the patients had Barrett’s CDQ in GERD Diagnosis
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Table 2. Carlsson-Dent Questionnaire Score, Endoscopic Esophagitis, 
H Study and Gastroesophageal Reflux Disease Diagnosis
CDQ score
Positive Negative
LA grade A or B
esophagitis
  3   6
All others
a 41 50
Total 44 56
pH study
Positive Negative
41 with positive 
CDQ score and negative 
endoscopic esophagitis
  8 33
By CDQ
Number of cases in this group 
that were confirmed by
endoscopy/pH study
GERD diagnosed 44 11
CDQ score
Positive Negative
All GERD 
by endoscopy + pH study
11   6
aNormal endoscopy, duodenal ulcer, gastric ulcer and insignificant 
lesions.
CDQ, Carlsson-Dent Questionnaire; LA, Los Angeles.
Data are expressed as number.
esophagus or cancer (Table 1). 
Forty-four cases were diagnosed with GERD by positive 
CDQ score. All 3 patients with LA grade B esophagitis showed 
positive CDQ score whereas all 6 patients with LA grade A 
esophagitis showed negative CDQ score. The remaining 41 pa-
tients (41%) with negative or insignificant endoscopic examina-
tion had 24 hour pH monitoring performed and 8 patients in this 
group presented with positive 24 hour pH monitoring tests. 
Overall, the diagnosis of GERD by CDQ was confirmed in 11 of 
44 (25%) using endoscopy and pH monitoring as standard and 
CDQ missed 6 patients with LA grade A esophagitis (Table 2). 
CDQ was able to identify 11 of 17 cases with GERD also de-
tected by endoscopy and 24 hour pH monitoring with the sensi-
tivity of 64%.
Discussion
GERD is a common problem encountered in clinical practice. 
Many modalities of diagnostic tools are available for GERD di-
agnosis, ie, symptom-based, endoscopy, PPI test and 24 hour 
pH monitoring. Symptom-based diagnosis is a readily available 
tool to all physicians. It creates neither discomfort nor complica-
tions compared to other modalities. Most of the guidelines for 
dyspepsia management accepted symptom-based diagnosis to ex-
clude GERD from dyspepsia and this approach is widely prac-
ticed in the Western society with high prevalence of GERD
22-25 
with acceptable sensitivity and specificity.
7 Structural questionnaire 
is one symptom-based diagnostic tool for GERD that had been 
developed to standardize this method. Various types of structural 
questionnaire had been reported in the literature
8-15 and studies 
pertaining to the performance of these questionnaires yielded 
conflicting results.
9-18 Currently, no structural questionnaire re-
ported in the literature has yet met the criteria of perfect tool as 
proposed by  Stanghellini and colleagues.
8 The CDQ was re-
ported by Carlsson et al
13 to have a sensitivity of 92% and specif-
icity of 19%. Numans et al
16 evaluated the CDQ in primary care 
setting and found that the performance of CDQ was not better 
than chance diagnosis by flipping a coin. Hung et al
17 reported a 
poor performance of CDQ in predicting esophagitis and only 
16% of patients with positive CDQ score had esophagitis de-
tected by endoscopy. Factors that may influence the accuracy of 
symptom-based tools in GERD diagnosis  include the prevalence 
of GERD in population studied, culture, ethnics, care setting and 
perception of the patients. The sensitivity of a tool will increase in 
proportion to the prevalence of disease in the population.
5,7 The 
sensitivity of CDQ in our study was 64% and this may be an 
overestimation due to the omission of pH monitoring in patients 
with insignificant endoscopic findings with CDQ score less than 
four will miss some patients with GERD. Only 25% of patients 
with GERD diagnosed by CDQ was confirmed by endoscopy or 
24 hour pH monitoring in our study. Our data together with data 
of Hung et al
17 showed a poor performance of CDQ in the area 
with low prevalence of GERD. The diagnosis of GERD by 
CDQ alone may lead to inappropriate management of patients if 
the physicians are pressing on with the GERD treatment. Some 
new versions of questionnaire such as frequency scale for the 
symptoms of GERD, S scale and others has been studied in 
Asian countries with promising results.
10-12,14,15 Further studies 
to validate these questionnaire in different population are needed 
to confirm the validity of these tools.
The limitations of our study include the followings: (1) the 
studied population was from a tertiary centre so it may not repre-
sent the population in the primary care setting where symp-
tom-based diagnosis is the primary tool; (2) the selection bias 
may increase the number of patients with functional heartburn Nisa Netinatsunton, et al
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and this may account for, to some extent, the increased number of 
patients with positive CDQ score without pathological GERD; 
(3) the number of the patients was rather small; (4) the omission 
of pH monitoring in patient with insignificant endoscopic find-
ings with CDQ score less than 4 might have missed some pa-
tients with GERD and the full assessment of CDQ performance 
in terms of sensitivity, specificity, positive predictive value and 
negative predictive value could not be performed; and (5) the us-
ing of 24 pH monitoring with abnormal acid exposure time alone 
as a gold standard for the diagnosis of non-erosive GERD may 
have misclassified patients with GERD who had normal acid ex-
posure and positive symptom sensitivity index, and patients with 
weak acid reflux or non-acid reflux. 
In conclusion, CDQ in our study of low GERD prevalence 
population diagnosed more GERD than endoscopy or pH 
monitoring. This may be because some patients with functional 
heartburn had been picked up by CDQ and some patients with 
GERD were not detected by endoscopy or pH monitoring. Due 
to limited availability of other diagnostic tools in this region, it is 
acceptable to use symptom-based diagnosis with a reserve that it 
may misclassify functional heartburn as GERD and the caring 
physicians should be willing to refer if poor or no response to PPI 
treatment occur rather than pressing on adding medication aim-
ing to treat GERD.
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